How to Apply for and Secure EU Funding for Collaborative IBD Research Projects

Area of Science:

• Biomedical research
• European Union funding initiatives
• Inflammatory Bowel Disease (IBD) research

Background:

• The European Union (EU) provides significant funding for collaborative research projects.
• The Horizon 2020 program, launched in 2015, succeeded FP7, offering new funding opportunities.
• Inflammatory Bowel Disease (IBD) presents numerous challenges, including chronic disease management, biomarker discovery, and the development of novel treatments.

Purpose of the Study:

• To introduce the Horizon 2020 funding instrument and its application procedures.
• To provide practical tips and strategies for successful project submissions.
• To illustrate these points using four successful IBD-focused projects: SADEL, IBD-BIOM, IBD Character, and BIOCYCLE.

Main Methods:

• Review of the Horizon 2020 funding program structure and call procedures.
• Analysis of successful grant applications within the IBD research field.
• Case study approach highlighting four specific IBD projects (SADEL, IBD-BIOM, IBD Character, BIOCYCLE).

Main Results:

• Horizon 2020 offers substantial opportunities for European collaborative research in IBD.
• Successful project submissions require a clear understanding of program objectives and procedures.
• Examples demonstrate effective strategies for securing funding in areas like chronic disease management, biomarker discovery, and therapeutic development for IBD.

Conclusions:

• The Horizon 2020 program is a vital resource for advancing IBD research in Europe.
• Strategic planning and understanding submission guidelines are crucial for funding success.
• Learning from successful projects can guide future research endeavors in inflammatory bowel disease.